Channel Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 32 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -47.71%
- Profit Growth 5.41%
- Ebitda -14.64%
- Net Worth 0.78%
- Total Assets -7.27%
About Channel Drugs
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1992PTC050417
- Company No.
050417
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Sep 1992
- Date of AGM
26 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Channel Drugs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harpreet Singh  | Director | 24-Sep-1992 | Current |
| Manmohan Singh | Director | 24-Sep-1992 | Current |
| Satmeet Chopra | Director | 03-Aug-2024 | Current |
Financial Performance of Channel Drugs.
Channel Drugs Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 47.71% decrease. The company also saw a slight improvement in profitability, with a 5.41% increase in profit. The company's net worth moved up by a moderate rise of 0.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Channel Drugs?
In 2017, Channel Drugs had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Channel Drugs?
Unlock and access historical data on people associated with Channel Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Channel Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Channel Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
